Researchers used 7-tesla proton magnetic resonance spectroscopy to measure glutamate in five brain regions in 47 people with first-episode psychosis who were not taking antipsychotic medication, and in 21 healthy controls. The regions were the anterior cingulate cortex, dorsolateral prefrontal cortex, basal ganglia, hippocampus and thalamus.

Glutamate concentrations did not differ between the groups in the main analyses. But in exploratory analyses, glutamate levels were significantly correlated across six of 10 pairs of regions in the psychosis group, with correlations ranging from 0.3 to 0.4; this pattern was not seen in the controls. Four of these correlations were associated with the severity of positive symptoms, such as hallucinations or delusions, although the abstract does not report the size or direction of those associations.